Latest Avoro Capital Advisors LLC Stock Portfolio
$7.51Billion– No. of Holdings #41
Avoro Capital Advisors LLC Performance:
2024 Q2: -0.44%YTD: 7.84%2023: 0.12%
Performance for 2024 Q2 is -0.44%, and YTD is 7.84%, and 2023 is 0.12%.
About Avoro Capital Advisors LLC and 13F Hedge Fund Stock Holdings
Avoro Capital Advisors LLC is a hedge fund based in NEW YORK, NY. On 10-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $7.8 Billions. In it's latest 13F Holdings report, Avoro Capital Advisors LLC reported an equity portfolio of $7.5 Billions as of 30 Jun, 2024.
The top stock holdings of Avoro Capital Advisors LLC are UTHR, MDGL, . The fund has invested 12.1% of it's portfolio in UNITED THERAPEUTICS CORP and 7.7% of portfolio in MADRIGAL PHARMACEUTICALS INC.
The fund managers got completely rid off VIKING THERAPEUTICS INC (VKTX), ALPINE IMMUNE SCIENCES INC (ALPN) and MACROGENICS INC (MGNX) stocks. They significantly reduced their stock positions in SAREPTA THERAPEUTICS INC (SRPT), SPDR SERIES TRUST - S&P BIOTECH (BIL) and VERA THERAPEUTICS INC (VERA). Avoro Capital Advisors LLC opened new stock positions in BICYCLE THERAPEUTICS PLC (BCYC), DYNE THERAPEUTICS INC. (DYN) and NEUROGENE INC. The fund showed a lot of confidence in some stocks as they added substantially to MERUS N V (MRUS), ALNYLAM PHARMCEUTICALS INC. (ALNY) and SOLENO THERAPEUTICS INC (SLNO).
The top stock holdings of Avoro Capital Advisors LLC are UTHR, MDGL, . The fund has invested 12.1% of it's portfolio in UNITED THERAPEUTICS CORP and 7.7% of portfolio in MADRIGAL PHARMACEUTICALS INC.
The fund managers got completely rid off VIKING THERAPEUTICS INC (VKTX), ALPINE IMMUNE SCIENCES INC (ALPN) and MACROGENICS INC (MGNX) stocks. They significantly reduced their stock positions in SAREPTA THERAPEUTICS INC (SRPT), SPDR SERIES TRUST - S&P BIOTECH (BIL) and VERA THERAPEUTICS INC (VERA). Avoro Capital Advisors LLC opened new stock positions in BICYCLE THERAPEUTICS PLC (BCYC), DYNE THERAPEUTICS INC. (DYN) and NEUROGENE INC. The fund showed a lot of confidence in some stocks as they added substantially to MERUS N V (MRUS), ALNYLAM PHARMCEUTICALS INC. (ALNY) and SOLENO THERAPEUTICS INC (SLNO).
Avoro Capital Advisors LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Avoro Capital Advisors LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Avoro Capital Advisors LLC made a return of -0.44% in the last quarter. In trailing 12 months, it's portfolio return was 9.03%.
New Buys
| Ticker | $ Bought |
|---|---|
| bicycle therapeutics plc | 14,168,000 |
| dyne therapeutics inc. | 4,084,850 |
| neurogene inc | 801,635 |
New stocks bought by Avoro Capital Advisors LLC
Additions
| Ticker | % Inc. |
|---|---|
| merus n v | 52.44 |
| alnylam pharmceuticals inc. | 33.33 |
| soleno therapeutics inc | 28.72 |
| intra-cellular therapies inc | 21.21 |
| ocular therapeutix inc | 12.74 |
| avidity biosciences inc | 11.67 |
| moonlake immunotherapeutics | 7.36 |
| ascendis pharma | 5.8 |
Additions to existing portfolio by Avoro Capital Advisors LLC
Reductions
| Ticker | % Reduced |
|---|---|
| sarepta therapeutics inc | -30.95 |
| spdr series trust - s&p biotech | -29.42 |
| vera therapeutics inc | -18.15 |
| kura oncology inc | -8.01 |
| syndax pharmaceuticals inc | -7.91 |
| krystal biotech inc | -4.8 |
| biocryst pharmaceuticals inc | -3.68 |
| mannkind corp | -2.67 |
Avoro Capital Advisors LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| macrogenics inc | -90,528,000 |
| alpine immune sciences inc | -228,921,000 |
| roivant sciences ltd | -49,023,200 |
| marinus pharmaceuticals inc | -37,431,100 |
| viking therapeutics inc | -294,380,000 |
| rocket pharmaceuticals inc | -33,968,600 |
| kyverna therapeutics inc | -11,799,000 |
| crispr therapeutics ag | -28,598,600 |
Avoro Capital Advisors LLC got rid off the above stocks
Sector Distribution
Avoro Capital Advisors LLC has about 80.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 80.9 |
| Others | 19.1 |
Market Cap. Distribution
Avoro Capital Advisors LLC has about 24.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 48 |
| LARGE-CAP | 24.7 |
| UNALLOCATED | 19.7 |
| SMALL-CAP | 6.9 |
Stocks belong to which Index?
About 41.3% of the stocks held by Avoro Capital Advisors LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 58.7 |
| RUSSELL 2000 | 41.3 |
Avoro Capital Advisors LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Avoro Capital Advisors LLC
Avoro Capital Advisors LLC has 41 stocks in it's portfolio. About 65.3% of the portfolio is in top 10 stocks. APLS proved to be the most loss making stock for the portfolio. UTHR was the most profitable stock for Avoro Capital Advisors LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | aadi biosciences inc | 0.06 | 2,849,400 | 4,160,130 | unchanged | 0.00 | ||
| ADVM | adverum biotechnologies inc | 0.04 | 416,666 | 2,858,330 | unchanged | 0.00 | ||
| AGLE | spyre therapeutics inc | 0.58 | 1,839,140 | 43,238,100 | unchanged | 0.00 | ||
| ALNY | alnylam pharmceuticals inc. | 1.29 | 400,000 | 97,200,000 | added | 33.33 | ||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLS | apellis pharmaceuticals inc. | 5.68 | 11,111,100 | 426,222,000 | unchanged | 0.00 | ||
| ARWR | arrowhead pharmaceuticals inc. | 3.08 | 8,888,890 | 231,022,000 | added | 3.9 | ||
| AUTL | autolus therapeutics plc | 0.57 | 12,345,700 | 42,963,000 | unchanged | 0.00 | ||
| BCRX | biocryst pharmaceuticals inc | 1.03 | 12,570,000 | 77,682,600 | reduced | -3.68 | ||
| BCYC | bicycle therapeutics plc | 0.19 | 700,000 | 14,168,000 | new | |||
| BIL | spdr series trust - s&p biotech | 3.75 | 3,035,000 | 281,375,000 | reduced | -29.42 | ||
| BMRN | biomarin pharmaceutical inc | 5.00 | 4,557,420 | 375,212,000 | added | 4.41 | ||
| CERE | cerevel therapeutics hldng | 4.11 | 7,539,550 | 308,292,000 | reduced | -0.21 | ||
| CRSP | crispr therapeutics ag | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DYN | dyne therapeutics inc. | 0.05 | 115,751 | 4,084,850 | new | |||
| FOLD | amicus therapeutics inc. | 3.62 | 27,400,000 | 271,808,000 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics inc | 0.23 | 4,535,000 | 16,960,900 | unchanged | 0.00 | ||
| IOVA | iovance biotherapeutics inc | 1.25 | 11,700,000 | 93,834,000 | unchanged | 0.00 | ||
| ITCI | intra-cellular therapies inc | 2.74 | 3,000,000 | 205,470,000 | added | 21.21 | ||
| KRYS | krystal biotech inc | 5.95 | 2,433,000 | 446,796,000 | reduced | -4.8 | ||